Brief: Galapagos NV Says Board Receives Non-Binding Offers For Cell Therapy Business
Oct 1 (Reuters) - Galapagos NV GLPG.AS: GALAPAGOS PROVIDES UPDATE ON STRATEGIC ALTERNATIVES FOR ITS CELL THERAPY BUSINESS GALAPAGOS NV - BOARD RECEIVES NON-BINDING OFFERS FOR CELL THERAPY BUSINESS GALAPAGOS NV - ANNOUNCEMENT ON CELL THERAPY STRATEGIC REVIEW EXPECTED BY NOV 5 GALAPAGOS NV: NON-BINDING OFFERS WERE FROM CONSORTIA, PREDOMINANTLY COMPRISED OF FINANCIAL INVESTORS, TO ACQUIRE CELL THERAPY BUSINESS Source text: ID:nGNXpsRtj Further company coverage: GLPG.AS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline
Brief: Lakefront Receives Transparency Notification From Bank Of America
Belgium's Galapagos Q1 revenue falls 91% but returns to profit
Brief: Galapagos, Gilead Enter Binding Agreement On Ouro Medicines Acquisition
Brief: Galapagos Announces Nomination Of Gino Santini To Its Board Of Directors